nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—CYP1A2—Carmustine—brain cancer	0.07	0.771	CbGbCtD
Pentoxifylline—CYP1A2—Etoposide—brain cancer	0.0208	0.229	CbGbCtD
Pentoxifylline—ADORA2A—ganglion—brain cancer	0.0159	0.0597	CbGeAlD
Pentoxifylline—ADORA1—ganglion—brain cancer	0.0137	0.0516	CbGeAlD
Pentoxifylline—PDE5A—endothelium—brain cancer	0.0125	0.0469	CbGeAlD
Pentoxifylline—PDE5A—blood vessel—brain cancer	0.0115	0.0433	CbGeAlD
Pentoxifylline—NT5E—telencephalon—brain cancer	0.0086	0.0323	CbGeAlD
Pentoxifylline—NT5E—gonad—brain cancer	0.00718	0.027	CbGeAlD
Pentoxifylline—NT5E—pituitary gland—brain cancer	0.007	0.0263	CbGeAlD
Pentoxifylline—PDE4A—telencephalon—brain cancer	0.00656	0.0247	CbGeAlD
Pentoxifylline—NT5E—midbrain—brain cancer	0.00617	0.0232	CbGeAlD
Pentoxifylline—ADORA2A—telencephalon—brain cancer	0.00613	0.023	CbGeAlD
Pentoxifylline—NT5E—spinal cord—brain cancer	0.00602	0.0227	CbGeAlD
Pentoxifylline—ADORA2B—pituitary gland—brain cancer	0.006	0.0226	CbGeAlD
Pentoxifylline—PDE5A—telencephalon—brain cancer	0.00558	0.021	CbGeAlD
Pentoxifylline—NT5E—endocrine gland—brain cancer	0.00542	0.0204	CbGeAlD
Pentoxifylline—NT5E—head—brain cancer	0.00535	0.0201	CbGeAlD
Pentoxifylline—ADORA1—telencephalon—brain cancer	0.00529	0.0199	CbGeAlD
Pentoxifylline—ADORA2A—gonad—brain cancer	0.00511	0.0192	CbGeAlD
Pentoxifylline—NT5E—central nervous system—brain cancer	0.00489	0.0184	CbGeAlD
Pentoxifylline—PDE5A—gonad—brain cancer	0.00466	0.0175	CbGeAlD
Pentoxifylline—ADORA2B—head—brain cancer	0.00459	0.0172	CbGeAlD
Pentoxifylline—ADORA2A—spinal cord—brain cancer	0.00429	0.0161	CbGeAlD
Pentoxifylline—ADORA2B—central nervous system—brain cancer	0.00419	0.0157	CbGeAlD
Pentoxifylline—ADORA1—medulla oblongata—brain cancer	0.00416	0.0156	CbGeAlD
Pentoxifylline—ADORA2B—cerebellum—brain cancer	0.00409	0.0154	CbGeAlD
Pentoxifylline—PDE4B—telencephalon—brain cancer	0.00391	0.0147	CbGeAlD
Pentoxifylline—NT5E—brain—brain cancer	0.00388	0.0146	CbGeAlD
Pentoxifylline—ADORA2A—endocrine gland—brain cancer	0.00386	0.0145	CbGeAlD
Pentoxifylline—ADORA2A—head—brain cancer	0.00382	0.0144	CbGeAlD
Pentoxifylline—ADORA1—midbrain—brain cancer	0.0038	0.0143	CbGeAlD
Pentoxifylline—ADORA1—spinal cord—brain cancer	0.00371	0.0139	CbGeAlD
Pentoxifylline—PDE4A—cerebellum—brain cancer	0.00365	0.0137	CbGeAlD
Pentoxifylline—PDE5A—endocrine gland—brain cancer	0.00352	0.0132	CbGeAlD
Pentoxifylline—ADORA2A—central nervous system—brain cancer	0.00348	0.0131	CbGeAlD
Pentoxifylline—PDE5A—head—brain cancer	0.00347	0.0131	CbGeAlD
Pentoxifylline—Caffeine—CYP2C9—brain cancer	0.00347	1	CrCbGaD
Pentoxifylline—ADORA2A—cerebellum—brain cancer	0.0034	0.0128	CbGeAlD
Pentoxifylline—ADORA1—endocrine gland—brain cancer	0.00334	0.0126	CbGeAlD
Pentoxifylline—ADORA2B—brain—brain cancer	0.00332	0.0125	CbGeAlD
Pentoxifylline—ADORA1—head—brain cancer	0.00329	0.0124	CbGeAlD
Pentoxifylline—PDE4B—gonad—brain cancer	0.00327	0.0123	CbGeAlD
Pentoxifylline—Aplastic anaemia—Temozolomide—brain cancer	0.00321	0.00657	CcSEcCtD
Pentoxifylline—PDE4B—pituitary gland—brain cancer	0.00319	0.012	CbGeAlD
Pentoxifylline—PDE5A—central nervous system—brain cancer	0.00317	0.0119	CbGeAlD
Pentoxifylline—Drowsiness—Procarbazine—brain cancer	0.00317	0.00647	CcSEcCtD
Pentoxifylline—Infection—Lomustine—brain cancer	0.00316	0.00646	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Lomustine—brain cancer	0.00311	0.00636	CcSEcCtD
Pentoxifylline—PDE5A—cerebellum—brain cancer	0.0031	0.0117	CbGeAlD
Pentoxifylline—Jaundice—Procarbazine—brain cancer	0.00309	0.00631	CcSEcCtD
Pentoxifylline—PDE4B—medulla oblongata—brain cancer	0.00307	0.0116	CbGeAlD
Pentoxifylline—Sweating—Procarbazine—brain cancer	0.00304	0.0062	CcSEcCtD
Pentoxifylline—Anorexia—Lomustine—brain cancer	0.00303	0.0062	CcSEcCtD
Pentoxifylline—ADORA1—central nervous system—brain cancer	0.00301	0.0113	CbGeAlD
Pentoxifylline—Epistaxis—Procarbazine—brain cancer	0.00299	0.0061	CcSEcCtD
Pentoxifylline—PDE4A—brain—brain cancer	0.00296	0.0111	CbGeAlD
Pentoxifylline—ADORA1—cerebellum—brain cancer	0.00294	0.0111	CbGeAlD
Pentoxifylline—Swelling—Carmustine—brain cancer	0.00291	0.00595	CcSEcCtD
Pentoxifylline—Ear pain—Temozolomide—brain cancer	0.00291	0.00595	CcSEcCtD
Pentoxifylline—Body temperature increased—Carboplatin—brain cancer	0.00287	0.00587	CcSEcCtD
Pentoxifylline—Haemoglobin—Procarbazine—brain cancer	0.00286	0.00584	CcSEcCtD
Pentoxifylline—Haemorrhage—Procarbazine—brain cancer	0.00284	0.00581	CcSEcCtD
Pentoxifylline—PDE4B—midbrain—brain cancer	0.00281	0.0106	CbGeAlD
Pentoxifylline—Vascular purpura—Temozolomide—brain cancer	0.00278	0.00567	CcSEcCtD
Pentoxifylline—Decreased appetite—Lomustine—brain cancer	0.00276	0.00565	CcSEcCtD
Pentoxifylline—ADORA2A—brain—brain cancer	0.00276	0.0104	CbGeAlD
Pentoxifylline—PDE4B—spinal cord—brain cancer	0.00274	0.0103	CbGeAlD
Pentoxifylline—Nasal congestion—Temozolomide—brain cancer	0.00273	0.00557	CcSEcCtD
Pentoxifylline—Flushing—Procarbazine—brain cancer	0.00264	0.00539	CcSEcCtD
Pentoxifylline—Thirst—Temozolomide—brain cancer	0.00261	0.00533	CcSEcCtD
Pentoxifylline—Pancytopenia—Hydroxyurea—brain cancer	0.00261	0.00533	CcSEcCtD
Pentoxifylline—Purpura—Temozolomide—brain cancer	0.00258	0.00527	CcSEcCtD
Pentoxifylline—Arrhythmia—Procarbazine—brain cancer	0.00254	0.00519	CcSEcCtD
Pentoxifylline—PDE5A—brain—brain cancer	0.00252	0.00947	CbGeAlD
Pentoxifylline—Body temperature increased—Lomustine—brain cancer	0.00251	0.00514	CcSEcCtD
Pentoxifylline—PDE4B—endocrine gland—brain cancer	0.00247	0.00928	CbGeAlD
Pentoxifylline—Infestation—Hydroxyurea—brain cancer	0.00245	0.00501	CcSEcCtD
Pentoxifylline—Drowsiness—Hydroxyurea—brain cancer	0.00245	0.00501	CcSEcCtD
Pentoxifylline—Infestation NOS—Hydroxyurea—brain cancer	0.00245	0.00501	CcSEcCtD
Pentoxifylline—PDE4B—head—brain cancer	0.00244	0.00917	CbGeAlD
Pentoxifylline—Tension—Procarbazine—brain cancer	0.00243	0.00496	CcSEcCtD
Pentoxifylline—Nervousness—Procarbazine—brain cancer	0.0024	0.00491	CcSEcCtD
Pentoxifylline—ADORA1—brain—brain cancer	0.00239	0.00898	CbGeAlD
Pentoxifylline—Tremor—Procarbazine—brain cancer	0.00232	0.00474	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00232	0.00474	CcSEcCtD
Pentoxifylline—Anaemia—Procarbazine—brain cancer	0.00229	0.00467	CcSEcCtD
Pentoxifylline—Swelling—Etoposide—brain cancer	0.00225	0.0046	CcSEcCtD
Pentoxifylline—PDE4B—central nervous system—brain cancer	0.00222	0.00837	CbGeAlD
Pentoxifylline—Leukopenia—Procarbazine—brain cancer	0.00221	0.00453	CcSEcCtD
Pentoxifylline—Haemoglobin—Hydroxyurea—brain cancer	0.00221	0.00452	CcSEcCtD
Pentoxifylline—Haemorrhage—Hydroxyurea—brain cancer	0.0022	0.0045	CcSEcCtD
Pentoxifylline—PDE4B—cerebellum—brain cancer	0.00217	0.00818	CbGeAlD
Pentoxifylline—Abdominal distension—Temozolomide—brain cancer	0.00216	0.00442	CcSEcCtD
Pentoxifylline—Convulsion—Procarbazine—brain cancer	0.00214	0.00438	CcSEcCtD
Pentoxifylline—Hypertension—Procarbazine—brain cancer	0.00214	0.00437	CcSEcCtD
Pentoxifylline—Pancytopenia—Carmustine—brain cancer	0.00211	0.00431	CcSEcCtD
Pentoxifylline—Myalgia—Procarbazine—brain cancer	0.00211	0.0043	CcSEcCtD
Pentoxifylline—Anxiety—Procarbazine—brain cancer	0.0021	0.00429	CcSEcCtD
Pentoxifylline—Dry mouth—Procarbazine—brain cancer	0.00206	0.00421	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Etoposide—brain cancer	0.00205	0.0042	CcSEcCtD
Pentoxifylline—Pancytopenia—Temozolomide—brain cancer	0.00204	0.00417	CcSEcCtD
Pentoxifylline—Confusional state—Procarbazine—brain cancer	0.00204	0.00416	CcSEcCtD
Pentoxifylline—Vomiting—Lomustine—brain cancer	0.00202	0.00413	CcSEcCtD
Pentoxifylline—Oedema—Procarbazine—brain cancer	0.00202	0.00413	CcSEcCtD
Pentoxifylline—Infection—Procarbazine—brain cancer	0.00201	0.0041	CcSEcCtD
Pentoxifylline—Shock—Procarbazine—brain cancer	0.00199	0.00406	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Procarbazine—brain cancer	0.00198	0.00404	CcSEcCtD
Pentoxifylline—Tachycardia—Procarbazine—brain cancer	0.00197	0.00403	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Procarbazine—brain cancer	0.00195	0.00399	CcSEcCtD
Pentoxifylline—Anorexia—Procarbazine—brain cancer	0.00192	0.00393	CcSEcCtD
Pentoxifylline—Erythema—Hydroxyurea—brain cancer	0.00191	0.00391	CcSEcCtD
Pentoxifylline—Infestation NOS—Temozolomide—brain cancer	0.00191	0.00391	CcSEcCtD
Pentoxifylline—Infestation—Temozolomide—brain cancer	0.00191	0.00391	CcSEcCtD
Pentoxifylline—Nausea—Lomustine—brain cancer	0.00189	0.00386	CcSEcCtD
Pentoxifylline—Hypotension—Procarbazine—brain cancer	0.00189	0.00386	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00184	0.00376	CcSEcCtD
Pentoxifylline—Insomnia—Procarbazine—brain cancer	0.00183	0.00373	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Temozolomide—brain cancer	0.00181	0.0037	CcSEcCtD
Pentoxifylline—Somnolence—Procarbazine—brain cancer	0.0018	0.00367	CcSEcCtD
Pentoxifylline—Haemoglobin—Carmustine—brain cancer	0.00179	0.00365	CcSEcCtD
Pentoxifylline—Haemorrhage—Carmustine—brain cancer	0.00178	0.00363	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Hydroxyurea—brain cancer	0.00178	0.00363	CcSEcCtD
Pentoxifylline—Anaemia—Hydroxyurea—brain cancer	0.00177	0.00362	CcSEcCtD
Pentoxifylline—PDE4B—brain—brain cancer	0.00177	0.00664	CbGeAlD
Pentoxifylline—Decreased appetite—Procarbazine—brain cancer	0.00176	0.00359	CcSEcCtD
Pentoxifylline—Haemoglobin—Temozolomide—brain cancer	0.00173	0.00353	CcSEcCtD
Pentoxifylline—Malaise—Hydroxyurea—brain cancer	0.00173	0.00353	CcSEcCtD
Pentoxifylline—Constipation—Procarbazine—brain cancer	0.00173	0.00353	CcSEcCtD
Pentoxifylline—Haemorrhage—Temozolomide—brain cancer	0.00172	0.00351	CcSEcCtD
Pentoxifylline—Hepatitis—Temozolomide—brain cancer	0.00172	0.00351	CcSEcCtD
Pentoxifylline—Leukopenia—Hydroxyurea—brain cancer	0.00171	0.0035	CcSEcCtD
Pentoxifylline—Bronchospasm—Etoposide—brain cancer	0.00169	0.00345	CcSEcCtD
Pentoxifylline—Feeling abnormal—Procarbazine—brain cancer	0.00166	0.0034	CcSEcCtD
Pentoxifylline—Convulsion—Hydroxyurea—brain cancer	0.00166	0.00339	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Procarbazine—brain cancer	0.00165	0.00337	CcSEcCtD
Pentoxifylline—Flushing—Carmustine—brain cancer	0.00165	0.00337	CcSEcCtD
Pentoxifylline—Pancytopenia—Etoposide—brain cancer	0.00163	0.00333	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00162	0.00331	CcSEcCtD
Pentoxifylline—Discomfort—Hydroxyurea—brain cancer	0.00161	0.00329	CcSEcCtD
Pentoxifylline—Urticaria—Procarbazine—brain cancer	0.0016	0.00328	CcSEcCtD
Pentoxifylline—Body temperature increased—Procarbazine—brain cancer	0.0016	0.00326	CcSEcCtD
Pentoxifylline—Abdominal pain—Procarbazine—brain cancer	0.0016	0.00326	CcSEcCtD
Pentoxifylline—Flushing—Temozolomide—brain cancer	0.00159	0.00326	CcSEcCtD
Pentoxifylline—Arrhythmia—Carmustine—brain cancer	0.00159	0.00325	CcSEcCtD
Pentoxifylline—Oedema—Hydroxyurea—brain cancer	0.00156	0.00319	CcSEcCtD
Pentoxifylline—Infection—Hydroxyurea—brain cancer	0.00155	0.00317	CcSEcCtD
Pentoxifylline—Immune system disorder—Temozolomide—brain cancer	0.00155	0.00317	CcSEcCtD
Pentoxifylline—Erythema—Carmustine—brain cancer	0.00155	0.00316	CcSEcCtD
Pentoxifylline—Infestation NOS—Etoposide—brain cancer	0.00153	0.00313	CcSEcCtD
Pentoxifylline—Infestation—Etoposide—brain cancer	0.00153	0.00313	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Hydroxyurea—brain cancer	0.00153	0.00313	CcSEcCtD
Pentoxifylline—Skin disorder—Hydroxyurea—brain cancer	0.00152	0.0031	CcSEcCtD
Pentoxifylline—CYP1A2—endocrine gland—brain cancer	0.00152	0.0057	CbGeAlD
Pentoxifylline—Back pain—Carmustine—brain cancer	0.0015	0.00306	CcSEcCtD
Pentoxifylline—Erythema—Temozolomide—brain cancer	0.0015	0.00306	CcSEcCtD
Pentoxifylline—Jaundice—Etoposide—brain cancer	0.00149	0.00305	CcSEcCtD
Pentoxifylline—Anorexia—Hydroxyurea—brain cancer	0.00149	0.00304	CcSEcCtD
Pentoxifylline—Hypersensitivity—Procarbazine—brain cancer	0.00149	0.00304	CcSEcCtD
Pentoxifylline—Dysgeusia—Temozolomide—brain cancer	0.00146	0.00299	CcSEcCtD
Pentoxifylline—Vision blurred—Carmustine—brain cancer	0.00146	0.00298	CcSEcCtD
Pentoxifylline—Tremor—Carmustine—brain cancer	0.00145	0.00296	CcSEcCtD
Pentoxifylline—Asthenia—Procarbazine—brain cancer	0.00145	0.00296	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Etoposide—brain cancer	0.00145	0.00296	CcSEcCtD
Pentoxifylline—Back pain—Temozolomide—brain cancer	0.00145	0.00296	CcSEcCtD
Pentoxifylline—Anaemia—Carmustine—brain cancer	0.00143	0.00292	CcSEcCtD
Pentoxifylline—Pruritus—Procarbazine—brain cancer	0.00143	0.00292	CcSEcCtD
Pentoxifylline—Agitation—Carmustine—brain cancer	0.00142	0.00291	CcSEcCtD
Pentoxifylline—Vision blurred—Temozolomide—brain cancer	0.00141	0.00288	CcSEcCtD
Pentoxifylline—Tremor—Temozolomide—brain cancer	0.0014	0.00286	CcSEcCtD
Pentoxifylline—Dyspnoea—Hydroxyurea—brain cancer	0.00139	0.00285	CcSEcCtD
Pentoxifylline—Somnolence—Hydroxyurea—brain cancer	0.00139	0.00284	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Temozolomide—brain cancer	0.00139	0.00284	CcSEcCtD
Pentoxifylline—Leukopenia—Carmustine—brain cancer	0.00139	0.00283	CcSEcCtD
Pentoxifylline—Anaemia—Temozolomide—brain cancer	0.00138	0.00283	CcSEcCtD
Pentoxifylline—Diarrhoea—Procarbazine—brain cancer	0.00138	0.00282	CcSEcCtD
Pentoxifylline—Dyspepsia—Hydroxyurea—brain cancer	0.00138	0.00281	CcSEcCtD
Pentoxifylline—Agitation—Temozolomide—brain cancer	0.00137	0.00281	CcSEcCtD
Pentoxifylline—Angioedema—Temozolomide—brain cancer	0.00137	0.00279	CcSEcCtD
Pentoxifylline—Decreased appetite—Hydroxyurea—brain cancer	0.00136	0.00278	CcSEcCtD
Pentoxifylline—Malaise—Temozolomide—brain cancer	0.00135	0.00276	CcSEcCtD
Pentoxifylline—Convulsion—Carmustine—brain cancer	0.00134	0.00274	CcSEcCtD
Pentoxifylline—Leukopenia—Temozolomide—brain cancer	0.00134	0.00274	CcSEcCtD
Pentoxifylline—Hypertension—Carmustine—brain cancer	0.00134	0.00273	CcSEcCtD
Pentoxifylline—Constipation—Hydroxyurea—brain cancer	0.00134	0.00273	CcSEcCtD
Pentoxifylline—Dizziness—Procarbazine—brain cancer	0.00134	0.00273	CcSEcCtD
Pentoxifylline—Palpitations—Temozolomide—brain cancer	0.00132	0.0027	CcSEcCtD
Pentoxifylline—Chest pain—Carmustine—brain cancer	0.00132	0.00269	CcSEcCtD
Pentoxifylline—Myalgia—Carmustine—brain cancer	0.00132	0.00269	CcSEcCtD
Pentoxifylline—Anxiety—Carmustine—brain cancer	0.00131	0.00268	CcSEcCtD
Pentoxifylline—Convulsion—Temozolomide—brain cancer	0.0013	0.00265	CcSEcCtD
Pentoxifylline—Hypertension—Temozolomide—brain cancer	0.00129	0.00264	CcSEcCtD
Pentoxifylline—Feeling abnormal—Hydroxyurea—brain cancer	0.00129	0.00263	CcSEcCtD
Pentoxifylline—Vomiting—Procarbazine—brain cancer	0.00128	0.00262	CcSEcCtD
Pentoxifylline—Flushing—Etoposide—brain cancer	0.00128	0.00261	CcSEcCtD
Pentoxifylline—Confusional state—Carmustine—brain cancer	0.00127	0.0026	CcSEcCtD
Pentoxifylline—Myalgia—Temozolomide—brain cancer	0.00127	0.0026	CcSEcCtD
Pentoxifylline—Rash—Procarbazine—brain cancer	0.00127	0.0026	CcSEcCtD
Pentoxifylline—Dermatitis—Procarbazine—brain cancer	0.00127	0.0026	CcSEcCtD
Pentoxifylline—Anxiety—Temozolomide—brain cancer	0.00127	0.00259	CcSEcCtD
Pentoxifylline—Headache—Procarbazine—brain cancer	0.00126	0.00259	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00126	0.00258	CcSEcCtD
Pentoxifylline—Oedema—Carmustine—brain cancer	0.00126	0.00258	CcSEcCtD
Pentoxifylline—Discomfort—Temozolomide—brain cancer	0.00126	0.00257	CcSEcCtD
Pentoxifylline—Infection—Carmustine—brain cancer	0.00126	0.00257	CcSEcCtD
Pentoxifylline—Dry mouth—Temozolomide—brain cancer	0.00125	0.00255	CcSEcCtD
Pentoxifylline—Immune system disorder—Etoposide—brain cancer	0.00124	0.00254	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Carmustine—brain cancer	0.00124	0.00253	CcSEcCtD
Pentoxifylline—Body temperature increased—Hydroxyurea—brain cancer	0.00124	0.00252	CcSEcCtD
Pentoxifylline—Tachycardia—Carmustine—brain cancer	0.00123	0.00252	CcSEcCtD
Pentoxifylline—Confusional state—Temozolomide—brain cancer	0.00123	0.00252	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Temozolomide—brain cancer	0.00122	0.0025	CcSEcCtD
Pentoxifylline—Oedema—Temozolomide—brain cancer	0.00122	0.0025	CcSEcCtD
Pentoxifylline—Infection—Temozolomide—brain cancer	0.00121	0.00248	CcSEcCtD
Pentoxifylline—Anorexia—Carmustine—brain cancer	0.0012	0.00246	CcSEcCtD
Pentoxifylline—Nausea—Procarbazine—brain cancer	0.0012	0.00245	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Temozolomide—brain cancer	0.0012	0.00244	CcSEcCtD
Pentoxifylline—Skin disorder—Temozolomide—brain cancer	0.00119	0.00242	CcSEcCtD
Pentoxifylline—Hypotension—Carmustine—brain cancer	0.00118	0.00241	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Temozolomide—brain cancer	0.00118	0.00241	CcSEcCtD
Pentoxifylline—Dysgeusia—Etoposide—brain cancer	0.00117	0.0024	CcSEcCtD
Pentoxifylline—Anorexia—Temozolomide—brain cancer	0.00116	0.00238	CcSEcCtD
Pentoxifylline—Back pain—Etoposide—brain cancer	0.00116	0.00237	CcSEcCtD
Pentoxifylline—Hypersensitivity—Hydroxyurea—brain cancer	0.00115	0.00235	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Carmustine—brain cancer	0.00115	0.00235	CcSEcCtD
Pentoxifylline—Muscle spasms—Etoposide—brain cancer	0.00115	0.00235	CcSEcCtD
Pentoxifylline—Insomnia—Carmustine—brain cancer	0.00114	0.00234	CcSEcCtD
Pentoxifylline—Dyspnoea—Carmustine—brain cancer	0.00113	0.0023	CcSEcCtD
Pentoxifylline—Somnolence—Carmustine—brain cancer	0.00112	0.0023	CcSEcCtD
Pentoxifylline—Asthenia—Hydroxyurea—brain cancer	0.00112	0.00229	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00111	0.00227	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Etoposide—brain cancer	0.00111	0.00227	CcSEcCtD
Pentoxifylline—Anaemia—Etoposide—brain cancer	0.00111	0.00226	CcSEcCtD
Pentoxifylline—Insomnia—Temozolomide—brain cancer	0.0011	0.00226	CcSEcCtD
Pentoxifylline—Decreased appetite—Carmustine—brain cancer	0.0011	0.00224	CcSEcCtD
Pentoxifylline—Dyspnoea—Temozolomide—brain cancer	0.00109	0.00222	CcSEcCtD
Pentoxifylline—Somnolence—Temozolomide—brain cancer	0.00109	0.00222	CcSEcCtD
Pentoxifylline—Constipation—Carmustine—brain cancer	0.00108	0.00221	CcSEcCtD
Pentoxifylline—Malaise—Etoposide—brain cancer	0.00108	0.00221	CcSEcCtD
Pentoxifylline—Dyspepsia—Temozolomide—brain cancer	0.00107	0.0022	CcSEcCtD
Pentoxifylline—Leukopenia—Etoposide—brain cancer	0.00107	0.00219	CcSEcCtD
Pentoxifylline—Diarrhoea—Hydroxyurea—brain cancer	0.00107	0.00219	CcSEcCtD
Pentoxifylline—Decreased appetite—Temozolomide—brain cancer	0.00106	0.00217	CcSEcCtD
Pentoxifylline—Constipation—Temozolomide—brain cancer	0.00104	0.00213	CcSEcCtD
Pentoxifylline—Feeling abnormal—Carmustine—brain cancer	0.00104	0.00213	CcSEcCtD
Pentoxifylline—Convulsion—Etoposide—brain cancer	0.00104	0.00212	CcSEcCtD
Pentoxifylline—Hypertension—Etoposide—brain cancer	0.00103	0.00211	CcSEcCtD
Pentoxifylline—Dizziness—Hydroxyurea—brain cancer	0.00103	0.00211	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Carmustine—brain cancer	0.00103	0.00211	CcSEcCtD
Pentoxifylline—Chest pain—Etoposide—brain cancer	0.00102	0.00208	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00101	0.00207	CcSEcCtD
Pentoxifylline—Discomfort—Etoposide—brain cancer	0.00101	0.00206	CcSEcCtD
Pentoxifylline—Feeling abnormal—Temozolomide—brain cancer	0.00101	0.00206	CcSEcCtD
Pentoxifylline—Abdominal pain—Carmustine—brain cancer	0.000999	0.00204	CcSEcCtD
Pentoxifylline—Body temperature increased—Carmustine—brain cancer	0.000999	0.00204	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Temozolomide—brain cancer	0.000998	0.00204	CcSEcCtD
Pentoxifylline—Vomiting—Hydroxyurea—brain cancer	0.000994	0.00203	CcSEcCtD
Pentoxifylline—Rash—Hydroxyurea—brain cancer	0.000985	0.00201	CcSEcCtD
Pentoxifylline—Confusional state—Etoposide—brain cancer	0.000985	0.00201	CcSEcCtD
Pentoxifylline—Dermatitis—Hydroxyurea—brain cancer	0.000984	0.00201	CcSEcCtD
Pentoxifylline—Headache—Hydroxyurea—brain cancer	0.000979	0.002	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Etoposide—brain cancer	0.000977	0.002	CcSEcCtD
Pentoxifylline—Infection—Etoposide—brain cancer	0.000971	0.00198	CcSEcCtD
Pentoxifylline—Urticaria—Temozolomide—brain cancer	0.00097	0.00198	CcSEcCtD
Pentoxifylline—Abdominal pain—Temozolomide—brain cancer	0.000965	0.00197	CcSEcCtD
Pentoxifylline—Body temperature increased—Temozolomide—brain cancer	0.000965	0.00197	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Etoposide—brain cancer	0.000956	0.00195	CcSEcCtD
Pentoxifylline—Tachycardia—Etoposide—brain cancer	0.000953	0.00195	CcSEcCtD
Pentoxifylline—Skin disorder—Etoposide—brain cancer	0.000949	0.00194	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Etoposide—brain cancer	0.000944	0.00193	CcSEcCtD
Pentoxifylline—Anorexia—Etoposide—brain cancer	0.000931	0.0019	CcSEcCtD
Pentoxifylline—Hypersensitivity—Carmustine—brain cancer	0.000931	0.0019	CcSEcCtD
Pentoxifylline—Nausea—Hydroxyurea—brain cancer	0.000928	0.0019	CcSEcCtD
Pentoxifylline—Hypotension—Etoposide—brain cancer	0.000913	0.00187	CcSEcCtD
Pentoxifylline—Asthenia—Carmustine—brain cancer	0.000906	0.00185	CcSEcCtD
Pentoxifylline—Hypersensitivity—Temozolomide—brain cancer	0.000899	0.00184	CcSEcCtD
Pentoxifylline—Asthenia—Temozolomide—brain cancer	0.000876	0.00179	CcSEcCtD
Pentoxifylline—Dyspnoea—Etoposide—brain cancer	0.000871	0.00178	CcSEcCtD
Pentoxifylline—Somnolence—Etoposide—brain cancer	0.000868	0.00177	CcSEcCtD
Pentoxifylline—Diarrhoea—Carmustine—brain cancer	0.000864	0.00177	CcSEcCtD
Pentoxifylline—Pruritus—Temozolomide—brain cancer	0.000864	0.00177	CcSEcCtD
Pentoxifylline—Decreased appetite—Etoposide—brain cancer	0.000849	0.00174	CcSEcCtD
Pentoxifylline—Dizziness—Carmustine—brain cancer	0.000835	0.00171	CcSEcCtD
Pentoxifylline—Constipation—Etoposide—brain cancer	0.000835	0.00171	CcSEcCtD
Pentoxifylline—Diarrhoea—Temozolomide—brain cancer	0.000835	0.00171	CcSEcCtD
Pentoxifylline—Dizziness—Temozolomide—brain cancer	0.000807	0.00165	CcSEcCtD
Pentoxifylline—Feeling abnormal—Etoposide—brain cancer	0.000805	0.00165	CcSEcCtD
Pentoxifylline—Vomiting—Carmustine—brain cancer	0.000803	0.00164	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Etoposide—brain cancer	0.000799	0.00163	CcSEcCtD
Pentoxifylline—Rash—Carmustine—brain cancer	0.000797	0.00163	CcSEcCtD
Pentoxifylline—Dermatitis—Carmustine—brain cancer	0.000796	0.00163	CcSEcCtD
Pentoxifylline—Headache—Carmustine—brain cancer	0.000791	0.00162	CcSEcCtD
Pentoxifylline—Vomiting—Temozolomide—brain cancer	0.000776	0.00159	CcSEcCtD
Pentoxifylline—Urticaria—Etoposide—brain cancer	0.000776	0.00159	CcSEcCtD
Pentoxifylline—Abdominal pain—Etoposide—brain cancer	0.000772	0.00158	CcSEcCtD
Pentoxifylline—Body temperature increased—Etoposide—brain cancer	0.000772	0.00158	CcSEcCtD
Pentoxifylline—Rash—Temozolomide—brain cancer	0.00077	0.00157	CcSEcCtD
Pentoxifylline—Dermatitis—Temozolomide—brain cancer	0.000769	0.00157	CcSEcCtD
Pentoxifylline—Headache—Temozolomide—brain cancer	0.000765	0.00156	CcSEcCtD
Pentoxifylline—Nausea—Carmustine—brain cancer	0.00075	0.00153	CcSEcCtD
Pentoxifylline—Nausea—Temozolomide—brain cancer	0.000725	0.00148	CcSEcCtD
Pentoxifylline—Hypersensitivity—Etoposide—brain cancer	0.00072	0.00147	CcSEcCtD
Pentoxifylline—Asthenia—Etoposide—brain cancer	0.000701	0.00143	CcSEcCtD
Pentoxifylline—Pruritus—Etoposide—brain cancer	0.000691	0.00141	CcSEcCtD
Pentoxifylline—Diarrhoea—Etoposide—brain cancer	0.000668	0.00137	CcSEcCtD
Pentoxifylline—Dizziness—Etoposide—brain cancer	0.000646	0.00132	CcSEcCtD
Pentoxifylline—Vomiting—Etoposide—brain cancer	0.000621	0.00127	CcSEcCtD
Pentoxifylline—Rash—Etoposide—brain cancer	0.000616	0.00126	CcSEcCtD
Pentoxifylline—Dermatitis—Etoposide—brain cancer	0.000615	0.00126	CcSEcCtD
Pentoxifylline—Headache—Etoposide—brain cancer	0.000612	0.00125	CcSEcCtD
Pentoxifylline—Nausea—Etoposide—brain cancer	0.00058	0.00119	CcSEcCtD
Pentoxifylline—ADORA2A—GPCR downstream signaling—ABR—brain cancer	0.00034	0.00226	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STRADA—brain cancer	0.000333	0.00221	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PDGFRA—brain cancer	0.00033	0.00219	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—TRPC6—brain cancer	0.000328	0.00218	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTCH2—brain cancer	0.000321	0.00213	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HES5—brain cancer	0.000311	0.00207	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—SHH—brain cancer	0.000309	0.00205	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—ABR—brain cancer	0.000309	0.00205	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DTX2—brain cancer	0.000306	0.00204	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STRADA—brain cancer	0.000302	0.00201	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTCH2—brain cancer	0.000301	0.002	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TRPC6—brain cancer	0.000298	0.00198	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—TRPC6—brain cancer	0.000298	0.00198	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTCH2—brain cancer	0.000297	0.00197	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PTCH1—brain cancer	0.000292	0.00194	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—SMO—brain cancer	0.000292	0.00194	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HES5—brain cancer	0.000291	0.00193	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IRS2—brain cancer	0.000289	0.00192	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HES5—brain cancer	0.000288	0.00191	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STRADA—brain cancer	0.000283	0.00188	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—SHH—brain cancer	0.00028	0.00186	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STRADA—brain cancer	0.000279	0.00186	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—TRPC6—brain cancer	0.000279	0.00185	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ABR—brain cancer	0.000278	0.00184	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—TRPC6—brain cancer	0.000275	0.00183	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TRPC6—brain cancer	0.00027	0.00179	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GLI2—brain cancer	0.000268	0.00178	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PTCH1—brain cancer	0.000266	0.00176	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—SMO—brain cancer	0.000266	0.00176	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—SHH—brain cancer	0.000262	0.00174	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—IL2—brain cancer	0.00026	0.00173	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—SHH—brain cancer	0.000259	0.00172	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	0.000258	0.00171	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TRPC6—brain cancer	0.000253	0.00168	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GLI1—brain cancer	0.000252	0.00167	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ABR—brain cancer	0.000252	0.00167	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TRPC6—brain cancer	0.00025	0.00166	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PTCH1—brain cancer	0.000249	0.00165	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—SMO—brain cancer	0.000249	0.00165	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PTCH1—brain cancer	0.000246	0.00163	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—SMO—brain cancer	0.000246	0.00163	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—VAV1—brain cancer	0.000245	0.00163	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GLI2—brain cancer	0.000243	0.00162	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000239	0.00159	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SUFU—brain cancer	0.000239	0.00159	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ABR—brain cancer	0.000236	0.00157	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ABR—brain cancer	0.000233	0.00155	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTCH2—brain cancer	0.000232	0.00154	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GFAP—brain cancer	0.000231	0.00153	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GLI1—brain cancer	0.000229	0.00152	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GLI2—brain cancer	0.000228	0.00151	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GLI2—brain cancer	0.000225	0.0015	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HES5—brain cancer	0.000225	0.00149	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—VAV1—brain cancer	0.000223	0.00148	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—VAV1—brain cancer	0.000223	0.00148	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—VEGFA—brain cancer	0.000221	0.00147	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HEY1—brain cancer	0.000219	0.00145	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STRADA—brain cancer	0.000218	0.00145	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SUFU—brain cancer	0.000217	0.00144	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000215	0.00143	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—TRPC6—brain cancer	0.000215	0.00143	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DLL1—brain cancer	0.000214	0.00142	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GLI1—brain cancer	0.000214	0.00142	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GLI1—brain cancer	0.000212	0.00141	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GFAP—brain cancer	0.000209	0.00139	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—VAV1—brain cancer	0.000209	0.00139	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—VAV1—brain cancer	0.000206	0.00137	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SUFU—brain cancer	0.000203	0.00135	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—SHH—brain cancer	0.000203	0.00134	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—VAV1—brain cancer	0.000202	0.00134	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SUFU—brain cancer	0.000201	0.00133	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—RELA—brain cancer	0.0002	0.00133	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HEY1—brain cancer	0.000198	0.00132	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—ERBB2—brain cancer	0.000198	0.00132	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TP53—brain cancer	0.000198	0.00132	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PIK3CG—brain cancer	0.000198	0.00131	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	0.000197	0.00131	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GFAP—brain cancer	0.000196	0.0013	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TRPC6—brain cancer	0.000195	0.0013	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DLL1—brain cancer	0.000195	0.00129	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GFAP—brain cancer	0.000194	0.00129	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PTCH1—brain cancer	0.000192	0.00128	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—SMO—brain cancer	0.000192	0.00128	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—VAV1—brain cancer	0.00019	0.00126	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—VAV1—brain cancer	0.000187	0.00124	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HEY1—brain cancer	0.000186	0.00123	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HEY1—brain cancer	0.000184	0.00122	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000183	0.00122	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SHH—brain cancer	0.000182	0.00121	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ABR—brain cancer	0.000182	0.00121	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DLL1—brain cancer	0.000182	0.00121	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DLL1—brain cancer	0.00018	0.0012	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	0.000179	0.00119	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GLI2—brain cancer	0.000176	0.00117	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TRPC6—brain cancer	0.000176	0.00117	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTCH1—brain cancer	0.000173	0.00115	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SMO—brain cancer	0.000173	0.00115	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000168	0.00112	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TP53—brain cancer	0.000167	0.00111	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SHH—brain cancer	0.000166	0.0011	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GLI1—brain cancer	0.000166	0.0011	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000165	0.00109	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000165	0.00109	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—VAV1—brain cancer	0.000161	0.00107	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TRPC6—brain cancer	0.00016	0.00106	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SUFU—brain cancer	0.000157	0.00104	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SMO—brain cancer	0.000157	0.00104	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTCH1—brain cancer	0.000157	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PIK3CG—brain cancer	0.000156	0.00103	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SHH—brain cancer	0.000155	0.00103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000154	0.00102	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SHH—brain cancer	0.000153	0.00102	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TP53—brain cancer	0.000153	0.00102	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GFAP—brain cancer	0.000151	0.00101	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—STAT3—brain cancer	0.000151	0.001	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TRPC6—brain cancer	0.000149	0.000992	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TRPC6—brain cancer	0.000148	0.000981	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTCH1—brain cancer	0.000147	0.000976	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SMO—brain cancer	0.000147	0.000976	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—VAV1—brain cancer	0.000146	0.000972	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTCH1—brain cancer	0.000145	0.000964	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SMO—brain cancer	0.000145	0.000964	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HEY1—brain cancer	0.000144	0.000953	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PIK3CG—brain cancer	0.000142	0.00094	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PIK3CG—brain cancer	0.000142	0.00094	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DLL1—brain cancer	0.000141	0.000934	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOTCH2—brain cancer	0.000138	0.000917	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—EGFR—brain cancer	0.000138	0.000913	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CG—brain cancer	0.000133	0.00088	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VAV1—brain cancer	0.000132	0.000874	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CG—brain cancer	0.000131	0.00087	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CG—brain cancer	0.000129	0.000853	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOTCH2—brain cancer	0.000125	0.000833	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CG—brain cancer	0.00012	0.000799	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SHH—brain cancer	0.00012	0.000795	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VAV1—brain cancer	0.00012	0.000794	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CG—brain cancer	0.000119	0.00079	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOTCH2—brain cancer	0.000117	0.00078	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOTCH2—brain cancer	0.000116	0.000771	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TRPC6—brain cancer	0.000115	0.000766	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTCH1—brain cancer	0.000113	0.000753	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SMO—brain cancer	0.000113	0.000753	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HES1—brain cancer	0.000113	0.000752	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000113	0.000749	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VAV1—brain cancer	0.000112	0.000743	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VAV1—brain cancer	0.000111	0.000735	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2—brain cancer	0.00011	0.000728	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PDGFRA—brain cancer	0.000108	0.000716	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SPP1—brain cancer	0.000105	0.000695	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HES1—brain cancer	0.000103	0.000683	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CG—brain cancer	0.000102	0.000679	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2—brain cancer	9.96e-05	0.000661	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2—brain cancer	9.96e-05	0.000661	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PDGFRA—brain cancer	9.79e-05	0.00065	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HES1—brain cancer	9.63e-05	0.000639	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HES1—brain cancer	9.52e-05	0.000632	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SPP1—brain cancer	9.51e-05	0.000631	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IRS2—brain cancer	9.47e-05	0.000629	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2—brain cancer	9.33e-05	0.000619	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CG—brain cancer	9.29e-05	0.000617	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2—brain cancer	9.22e-05	0.000612	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PDGFRA—brain cancer	9.17e-05	0.000609	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOTCH2—brain cancer	9.07e-05	0.000602	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PDGFRA—brain cancer	9.06e-05	0.000602	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2—brain cancer	9.04e-05	0.000601	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SPP1—brain cancer	8.9e-05	0.000591	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SPP1—brain cancer	8.8e-05	0.000584	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VAV1—brain cancer	8.65e-05	0.000574	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IRS2—brain cancer	8.6e-05	0.000571	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2—brain cancer	8.47e-05	0.000562	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2—brain cancer	8.37e-05	0.000556	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APC—brain cancer	8.36e-05	0.000555	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CG—brain cancer	8.36e-05	0.000555	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IRS2—brain cancer	8.05e-05	0.000535	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IRS2—brain cancer	7.95e-05	0.000528	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—brain cancer	7.62e-05	0.000506	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APC—brain cancer	7.59e-05	0.000504	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CG—brain cancer	7.59e-05	0.000504	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HES1—brain cancer	7.44e-05	0.000494	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2—brain cancer	7.2e-05	0.000478	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CG—brain cancer	7.11e-05	0.000472	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APC—brain cancer	7.11e-05	0.000472	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PDGFRA—brain cancer	7.08e-05	0.00047	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CG—brain cancer	7.03e-05	0.000466	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APC—brain cancer	7.03e-05	0.000466	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—brain cancer	6.92e-05	0.000459	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SPP1—brain cancer	6.87e-05	0.000456	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2C9—brain cancer	6.87e-05	0.000456	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—brain cancer	6.54e-05	0.000434	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RELA—brain cancer	6.53e-05	0.000434	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB2—brain cancer	6.49e-05	0.000431	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—brain cancer	6.48e-05	0.00043	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—brain cancer	6.4e-05	0.000425	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IRS2—brain cancer	6.22e-05	0.000413	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RELA—brain cancer	5.93e-05	0.000394	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB2—brain cancer	5.9e-05	0.000391	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—brain cancer	5.88e-05	0.000391	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BSG—brain cancer	5.84e-05	0.000388	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCND1—brain cancer	5.74e-05	0.000381	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CTNNB1—brain cancer	5.68e-05	0.000377	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RELA—brain cancer	5.56e-05	0.000369	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB2—brain cancer	5.52e-05	0.000367	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APC—brain cancer	5.49e-05	0.000364	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RELA—brain cancer	5.49e-05	0.000364	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CG—brain cancer	5.49e-05	0.000364	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB2—brain cancer	5.45e-05	0.000362	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—brain cancer	5.34e-05	0.000355	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCND1—brain cancer	5.21e-05	0.000346	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CTNNB1—brain cancer	5.16e-05	0.000342	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—IDH1—brain cancer	5.02e-05	0.000334	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—brain cancer	5e-05	0.000332	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—brain cancer	5e-05	0.000332	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—brain cancer	5e-05	0.000332	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT3—brain cancer	4.95e-05	0.000329	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—brain cancer	4.94e-05	0.000328	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCND1—brain cancer	4.88e-05	0.000324	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CTNNB1—brain cancer	4.83e-05	0.000321	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCND1—brain cancer	4.82e-05	0.00032	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CTNNB1—brain cancer	4.77e-05	0.000317	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—brain cancer	4.6e-05	0.000305	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—brain cancer	4.54e-05	0.000302	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—brain cancer	4.5e-05	0.000299	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT3—brain cancer	4.5e-05	0.000299	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RELA—brain cancer	4.29e-05	0.000285	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB2—brain cancer	4.26e-05	0.000283	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—brain cancer	4.25e-05	0.000282	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT3—brain cancer	4.21e-05	0.00028	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—brain cancer	4.2e-05	0.000279	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—brain cancer	4.18e-05	0.000277	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT3—brain cancer	4.16e-05	0.000276	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.09e-05	0.000272	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—brain cancer	4.09e-05	0.000271	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ENO2—brain cancer	3.97e-05	0.000264	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—brain cancer	3.91e-05	0.00026	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—brain cancer	3.87e-05	0.000257	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—brain cancer	3.86e-05	0.000256	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—brain cancer	3.83e-05	0.000254	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—brain cancer	3.78e-05	0.000251	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—brain cancer	3.78e-05	0.000251	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCND1—brain cancer	3.77e-05	0.00025	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CTNNB1—brain cancer	3.73e-05	0.000248	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—brain cancer	3.43e-05	0.000228	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—brain cancer	3.28e-05	0.000218	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT3—brain cancer	3.25e-05	0.000216	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—brain cancer	3.21e-05	0.000213	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—brain cancer	3.17e-05	0.000211	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—brain cancer	3.02e-05	0.000201	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—brain cancer	2.95e-05	0.000196	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—brain cancer	2.48e-05	0.000165	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CG—brain cancer	1.82e-05	0.000121	CbGpPWpGaD
